David Nadal

Author PubWeight™ 65.80‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J Exp Med 2008 3.85
2 Revisiting human IL-12Rβ1 deficiency: a survey of 141 patients from 30 countries. Medicine (Baltimore) 2010 2.33
3 Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor beta1 deficiency: medical and immunological implications. J Exp Med 2003 2.19
4 Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study. J Clin Oncol 2010 1.81
5 Real-time quantitative broad-range PCR assay for detection of the 16S rRNA gene followed by sequencing for species identification. J Clin Microbiol 2006 1.49
6 The diagnosis of brain tuberculoma by (1)H-magnetic resonance spectroscopy. Eur J Pediatr 2011 1.39
7 Prevalence of enteroaggregative Escherichia coli among children with and without diarrhea in Switzerland. J Clin Microbiol 2003 1.28
8 Plasma cell toll-like receptor (TLR) expression differs from that of B cells, and plasma cell TLR triggering enhances immunoglobulin production. Immunology 2009 1.23
9 Optimized virus disruption improves detection of HIV-1 p24 in particles and uncovers a p24 reactivity in patients with undetectable HIV-1 RNA under long-term HAART. J Med Virol 2006 1.19
10 Infective endocarditis in congenital heart disease. Eur J Pediatr 2011 1.15
11 Prospective surveillance of hospitalisations associated with varicella-zoster virus infections in children and adolescents. Eur J Pediatr 2005 1.14
12 Adaptation of the ultrasensitive HIV-1 p24 antigen assay to dried blood spot testing. J Acquir Immune Defic Syndr 2007 1.14
13 Three consecutive outbreaks of Serratia marcescens in a neonatal intensive care unit. Clin Infect Dis 2002 1.13
14 Is the in vitro interferon-gamma release assay an adequate replacement for the tuberculin skin test? Clin Infect Dis 2002 1.10
15 Sex and gender differences in travel-associated disease. Clin Infect Dis 2010 1.05
16 Quantitative detection of Moraxella catarrhalis in nasopharyngeal secretions by real-time PCR. J Clin Microbiol 2003 1.04
17 Quantitative profiling of housekeeping and Epstein-Barr virus gene transcription in Burkitt lymphoma cell lines using an oligonucleotide microarray. Virol J 2006 1.00
18 Inadequate clearance of translocated bacterial products in HIV-infected humanized mice. PLoS Pathog 2010 1.00
19 Profile of travel-associated illness in children, Zürich, Switzerland. J Travel Med 2012 0.99
20 Cellular immune responses and disease control in acute AIDS-associated Kaposi's sarcoma. AIDS 2009 0.98
21 Distinct ex vivo susceptibility of B-cell subsets to epstein-barr virus infection according to differentiation status and tissue origin. J Virol 2008 0.97
22 A distinct subpopulation of human NK cells restricts B cell transformation by EBV. J Immunol 2013 0.95
23 Immune activation suppresses initiation of lytic Epstein-Barr virus infection. Cell Microbiol 2007 0.93
24 Quantitative cytokine gene expression in human tonsils at excision and during histoculture assessed by standardized and calibrated real-time PCR and novel data processing. J Immunol Methods 2003 0.92
25 HIV-1 does not provoke alteration of cytokine gene expression in lymphoid tissue after acute infection ex vivo. J Immunol 2004 0.92
26 Use of simple heuristics to target macrolide prescription in children with community-acquired pneumonia. Arch Pediatr Adolesc Med 2002 0.92
27 Detection of Haemophilus influenzae type b by real-time PCR. J Clin Microbiol 2004 0.91
28 Diffusion tensor imaging in progressive multifocal leukoencephalopathy: early predictor for demyelination? AJNR Am J Neuroradiol 2005 0.90
29 G-CSF and IL-8 for early diagnosis of sepsis in neonates and critically ill children - safety and cost effectiveness of a new laboratory prediction model: study protocol of a randomized controlled trial [ISRCTN91123847]. Crit Care 2004 0.90
30 Pediatric epstein-barr virus carriers with or without tonsillar enlargement may substantially contribute to spreading of the virus. J Infect Dis 2010 0.90
31 Randomised trial of oral versus sequential intravenous/oral cephalosporins in children with pyelonephritis. Eur J Pediatr 2007 0.90
32 Hyperlipidemia in HIV-infected children treated with protease inhibitors: relevance for cardiovascular diseases. J Acquir Immune Defic Syndr 2002 0.89
33 beta1 integrin expression increases susceptibility of memory B cells to Epstein-Barr virus infection. J Virol 2010 0.88
34 Conservative management of acute appendicitis in children with hematologic malignancies during chemotherapy-induced neutropenia. J Pediatr Hematol Oncol 2008 0.88
35 Human tonsillar tissue block cultures differ from autologous tonsillar cell suspension cultures in lymphocyte subset activation and cytokine gene expression. J Immunol Methods 2004 0.88
36 Monitoring intracellular replication of Chlamydophila (Chlamydia) pneumoniae in cell cultures and comparing clinical samples by real-time PCR. Diagn Microbiol Infect Dis 2003 0.87
37 Predicting bacteremia in children with cancer and fever in chemotherapy-induced neutropenia: results of the prospective multicenter SPOG 2003 FN study. Pediatr Infect Dis J 2011 0.87
38 Long-term safety and effectiveness of lopinavir/ritonavir in antiretroviral-experienced HIV-1-infected children. Arch Dis Child 2010 0.87
39 Turicella otitidis and Corynebacterium auris do not cause otitis media with effusion in children. Pediatr Infect Dis J 2002 0.86
40 Real-time broad-range PCR versus blood culture. A prospective pilot study in pediatric cancer patients with fever and neutropenia. Support Care Cancer 2007 0.86
41 Clinical usefulness of serum EBV DNA levels of BamHI W and LMP1 for Nasal NK/T-cell lymphoma. J Med Virol 2007 0.85
42 Serious medical complications in children with cancer and fever in chemotherapy-induced neutropenia: results of the prospective multicenter SPOG 2003 FN study. Pediatr Blood Cancer 2011 0.85
43 Zebularine reactivates silenced E-cadherin but unlike 5-Azacytidine does not induce switching from latent to lytic Epstein-Barr virus infection in Burkitt's lymphoma Akata cells. Mol Cancer 2007 0.84
44 Innate immune responses against Epstein Barr virus infection. J Leukoc Biol 2013 0.84
45 Determinants of vaccine immunity in the cohort of human immunodeficiency virus-infected children living in Switzerland. Pediatr Infect Dis J 2009 0.83
46 Diagnostic accuracy of G-CSF, IL-8, and IL-1ra in critically ill children with suspected infection. Intensive Care Med 2002 0.83
47 Silencing of latent membrane protein 2B reduces susceptibility to activation of lytic Epstein-Barr virus in Burkitt's lymphoma Akata cells. J Gen Virol 2007 0.83
48 HIV interferes with SOCS-1 and -3 expression levels driving immune activation. Eur J Immunol 2011 0.83
49 Latent membrane protein 2B regulates susceptibility to induction of lytic Epstein-Barr virus infection. J Virol 2007 0.83
50 Low postseroconversion CD4 count and rapid decrease of CD4 density identify HIV+ fast progressors. AIDS Res Hum Retroviruses 2010 0.83
51 Distribution patterns of beta- and gamma-herpesviruses within Waldeyer's ring organs. J Med Virol 2007 0.82
52 Long-term safety and effectiveness of ritonavir, nelfinavir, and lopinavir/ritonavir in antiretroviral-experienced HIV-infected children. Pediatr Infect Dis J 2008 0.82
53 Tissue engineering of skin: human tonsil-derived mesenchymal cells can function as dermal fibroblasts. Pediatr Surg Int 2014 0.81
54 Prevalence of nosocomial infections in Swiss children's hospitals. Infect Control Hosp Epidemiol 2004 0.81
55 Evaluation of p24-based antiretroviral treatment monitoring in pediatric HIV-1 infection: prediction of the CD4+ T-cell changes between consecutive visits. J Acquir Immune Defic Syndr 2006 0.79
56 Rates of detection of Neisseria meningitidis in tonsils differ in relation to local incidence of invasive disease. J Clin Microbiol 2002 0.79
57 Role of latent membrane protein 2 isoforms in Epstein-Barr virus latency. Trends Microbiol 2008 0.79
58 Oropharyngeal group A streptococcal colonization disrupts latent Epstein-Barr virus infection. J Infect Dis 2013 0.79
59 Monocyte function-associated antigen expression during and after pediatric cardiac surgery. J Thorac Cardiovasc Surg 2005 0.78
60 B cells from HIV-infected patients with primary central nervous system lymphoma display an activated phenotype and have a blunted TNF-α response to TLR9 triggering. AIDS Res Hum Retroviruses 2010 0.77
61 Early gene expression changes by Epstein-Barr virus infection of B-cells indicate CDKs and survivin as therapeutic targets for post-transplant lymphoproliferative diseases. Int J Cancer 2013 0.77
62 Epstein-Barr virus load correlating with clinical manifestation and treatment response in a patient with angioimmunoblastic T-cell lymphoma. Antivir Ther 2004 0.77
63 Understanding TLR9 action in Epstein-Barr virus infection. Front Biosci (Landmark Ed) 2012 0.77
64 Determinants of hepatitis A vaccine immunity in a cohort of human immunodeficiency virus-infected children living in Switzerland. Clin Vaccine Immunol 2012 0.77
65 Withholding initial vancomycin in febrile neutropenia despite implanted catheters. Eur J Pediatr 2004 0.76
66 The swiss transplant cohort study: lessons from the first 6 years. Curr Infect Dis Rep 2015 0.76
67 A prospective multicenter study of microbiologically defined infections in pediatric cancer patients with fever and neutropenia: Swiss Pediatric Oncology Group 2003 fever and neutropenia study. Pediatr Infect Dis J 2014 0.75
68 Detection and molecular characterization of Cryptosporidium spp. isolated from diarrheic children in Switzerland. Pediatr Infect Dis J 2004 0.75
69 Management of Children with Travel-related Illness Evaluated in a Pediatric Emergency Room. Pediatr Infect Dis J 2015 0.75
70 Relevance of cohort studies for the study of transplant infectious diseases. Curr Opin Organ Transplant 2012 0.75
71 Non-invasive diagnosis of lung tuberculosis in children by single voxel ¹H-magnetic resonance spectroscopy. Eur J Pediatr 2012 0.75
72 Interventions using foreign material to treat congenital heart disease in children increase the risk for infective endocarditis. Pediatr Infect Dis J 2008 0.75
73 Hindsight judgement on ambiguous episodes of suspected infection in critically ill children: poor consensus amongst experts? Eur J Pediatr 2003 0.75
74 Unrecognized pediatric adult-type tuberculosis puts school contacts at risk. Pediatr Infect Dis J 2014 0.75